Urinary tract infections (UTIs) are classified by the host condition. Uncomplicated infections are caused most commonly by uropathogenic Escherichia coli (UPEC) and affect otherwise healthy people, whereas complicated infections are commonly caused by species, such as Proteus mirabilis, and affect patients with underlying difficulties, such as a urinary tract abnormality or catheterization. The outcome of infection caused by these bacteria is dictated by the immune response to the UTI and the host factors that influence the susceptibility to disease. This review focuses on the host pathogen interactions in UTI, including an identification of additional virulence factors and therapeutic or prophylactic targets, particularly by UPEC and P. mirabilis.
INTRODUCTION
Urinary tract infection (UTI), one of the most common bacterial infections, affects approximately 150 million people annually worldwide [1] . Clinically, UTIs are categorized as uncomplicated or complicated. Uncomplicated UTIs occur in relatively healthy individuals, whereas complicated UTIs occur in patients, who have structural or functional abnormalities in their urinary tract, are immunocompromised, undergoing long-term catheterization, or suffering from other illnesses. In more than 80% of cases, uncomplicated UTIs are caused by Escherichia coli.
On the other hand, complicated UTIs, particularly those associated with long-term catheterization, are often polymicrobial, generally caused by Proteus mirabilis, Providencia stuartii, Morganella morganii, Klebsiella pneumonia, and Pseudomonas aeruginosa [2] [3] [4] . These bacterial infections manifest as a series of measures and countermeasures by the host and pathogen that eventually settle the course of the disease. Strong host defense mechanisms stimulate changes in the expression of virulence factors in bacteria, which further promote new host defenses. One goal of a pathogen is to resist the host defense mechanisms and establish a persistent infection. To prevent clearance by innate or adaptive defenses, microbes must either avoid immune recognition or resist the antibacterial mechanisms utilized by the host. Irrespective of the mechanism, for survival, the bacteria must adapt to the environment produced by host pathogen interactions [2] . This review focuses on the host pathogen interactions in UTI, particularly by uropathogenic E. coli (UPEC) and P. mirabilis, as the archetypal pathogens causing uncomplicated and complicated UTI, respectively.
MECHANISM OF INFECTIONS AND VIR-ULENCE FACTORS
intestinal tract, which is the likely source of organisms infecting the urinary tract. UPEC are a specific subset of extraintestinal pathogenic E. coli; not all strains of E. coli cause UTI [5] . On the other hand, all strains of P. mirabilis, regardless of isolate origin, can cause UTI [6] . Horizontally acquired genetic elements have been identified in both species; UPEC strains have up to 13 pathogenicity islands [7] , and an integrative and conjugative element was recently identified in P. mirabilis [8] . Horizontal gene transfer is associated with bacterial pathogenesis because these horizontally transferred genes often encode traits that contribute to virulence, niche specificity, or antibiotic resistance [9] .
Recent studies have used RNA sequencing to analyze uropathogens directly from the urine of women undergoing symptomatic UTIs. These studies, together with basic science and improved animal models, have helped better understand the common strategies of pathogenesis by both UPEC and P. mirabilis, such as adherence, motility, acquisition of metals, toxin production, and immune evasion. Therefore, these studies have revealed key virulence factors that can be aimed at counteracting the pathogens and preventing UTIs [10, 11] .
UPEC

1) Adherence and colonization
During UTIs, UPEC pathogenesis includes the following:
(1) colonization of the periurethral, urethral, and vaginal areas; (2) ascent into the bladder lumen and growth as planktonic cells in urine; (3) adherence to the surface and interaction with the bladder epithelium defense system; (4) biofilm formation; (5) invasion and replication by forming bladder intracellular bacterial communities (IBCs), where quiescent intracellular reservoirs form and reside in the underlying urothelium; and (6) kidney colonization and host tissue damage with an increased risk of bacteremia/ septicemia [12] .
UPEC colonize the bladder using diverse virulence factors that play critical roles in the pathogenesis of UTI: surface structural components, such as lipopolysaccharide (LPS), polysaccharide capsule, flagella, pili, non-pilus adhesins, curli, outer-membrane vesicles, outer-membrane proteins, secreted toxins, secretion systems, and TonB-dependent iron-uptake receptors, including siderophore receptors [13] .
LPS are amphipathic molecules, consisting of fatty acids lined to an oligosaccharide core, stuck to a long polysaccharide chain, commonly called the O antigen. LPS mediate multiple aspects of the UPEC life cycle, including the ability to acutely colonize bladders, fashion reservoirs, and arouse the innate and adaptive immune responses [14] .
Moreover, LPS provides resistance against hydrophobic antibiotics, such as some antibiotics and bile salts, which form when LPS is decreased at the cell surface [15] .
In UPEC, the fim operon encodes type 1 pili exhibiting mannose-sensitive hemagglutination, whereas the pap operon encodes P-or Pap-pili that are capable of interacting with the digalactoside unit in the P-blood group antigen. The chaperone-usher pathway (CUP) assembles the pili. Type 1 pili are tipped with the adhesin FimH, which recognizes mannosylated uroplakins and 13 integrins with stereochemical specificity, initiating colonization and invasion into umbrella cells [16] . Type 1 pili, combining these cells, triggers a signal transduction cascade, activating Rho GTPases, such as those from the Rac family, causing actin rearrangement, and internalization of UPEC via a zippering mechanism composing a plasma membrane sheathe that engulfs the bacterium [17] . Moreover, the expression of type 1 pili is administered stringently by a phase variation, which reversibly diverts between the type 1 pili active expression (Phase-ON, piliated cells) and a loss of expression (Phase-OFF, non-piliated cells). Environmental signs within the urinary tract, such as salt growth conditions and acidic pH, manage stringently the molecular pathways involved in reversible diverting between the ON-OFF Phases [18] .
Unlike the mannose-binding adhesion (FimH) of type 1 pili, the adhesin of P pili (PapG) sticks globosides containing glycolipids that are present in the kidneys [19] . In addition, PapG modulates the local secretory-antibody immune response by interacting with TLR4 to reduce the level of polymeric immunoglobulin receptor expression, impairing immunoglobulin (Ig)A transport through the lamina propria and epithelial cells to the kidney lumen. This mechanism helps UPEC evade a key host protective mechanism, allowing the establishment of ascending infection [20] . of CsgA, whereas CsgB nucleates CsgA subunits into curli fibers [21] .
While pili are involved in the first attachment of UPEC to the urinary tract mucosa, UPEC employs several other afimbrial adhesins. The adhesin TosA was found in approximately 30% of urinary tract isolates [22] . Another adhesin FdeC aided colonization of the kidneys and bladder in a mouse infection model [23] , whereas the iron-regulated adhesin (Iha) mediates adherence to bladder epithelial cells [24] .
2) Other toxins
UPEC fabricates three main types of toxin: -hemolysin (HlyA), cytotoxic necrotizing factor 1 (CNF1), and secreted autotransporter toxins [9] . HlyA forms pores in the umbrella and promotes their lysis, facilitating iron and nutrient acquisition by the bacteria. HlyA also triggers exfoliation, exposing deeper layers of the uroepithelium for colonization and promoting bacterial spread to other hosts following cell expulsion in the urine [25, 26] . CNF1 influences actin remodeling in the host cell through three small RHO GTPases: RAC1, RHOA, and cell division control. CNF1 enters the host cell in endocytic vesicles, by sticking to the basal cell adhesion molecule receptor, constitutively initiating RHO GTPases via the deamination of a glutamine residue; this generates actin cytoskeletal rearrangements and membrane ruffling, guiding increased bacterial internalization [27] .
CNF1 is not necessary for infection but might be a fitness factor [9] . UPEC also secretes autotransporter toxins. Sat (secreted autotransporter toxin) is a serine protease that intercedes in the cytopathic effects on the kidney and bladder cell lines in vitro and causes tissue damage and immune responses in infected mice [28] . The autotransporter, Pic, with serine protease activity, is expressed during infection, but it does not aid in colonization. Another autotransporter Tsh, which lacks detectable serine protease activity, is expressed during infection in mice [29] .
3) Flagella-mediated motility
Similar to adherence, motility is another trait often associated with bacterial virulence. Complex surface structures called flagella mediate motility. UPEC is capable of flagellamediated motility, which contributes to the fitness of UPEC during a UTI and the ascension of infection [30] .
4) Metal acquisition
Iron, an essential nutrient, is isolated by the host, and successful bacterial pathogens must have the means to acquire it. Therefore, iron acquisition is a crucial requirement for UPEC survival. Consequently, IBC UPEC often shows the upregulation of redundant systems for iron acquisition.
Siderophores are small molecule iron chelators provided by UPEC strains to scavenge ferric ions (Fe 3+ ). UPEC produces several siderophores, of which aerobactin and yersiniabactin are essential in the urinary tract [13, 31] . Aerobactin is expressed strongly, stable at low pH, and displays higher iron sticking capacity than enterobactin. Yersiniabactin is important in bio-film formation in urine and protects against intracellular killing by copper stress because it sequesters host-derived copper [32] .
Pathogens can usually scavenge Fe from precursors, such as heme and hemoglobin. UPEC contains two outer membrane heme receptors, ChuA and Hma. Heme uptake via these receptors contributes to fitness during a UTI; the hma mutant outcompetes the chuA mutant, indicating that ChuA is the predominant heme transporter [33] . Moreover, ChuA aids in the intracellular growth of UPEC in bladder epithelial cells. During intracellular growth, chuA is expressed strongly, and its mutant fails to grow at the wild-type level. Heme uptake systems contribute to fitness during extracellular and intracellular growth in UPEC [34] .
Similarly, zinc is another essential nutrient sequestered by the effectors of nutritional immunity. Two distinct zinc import systems, ZnuACB and ZupT, operate in UPEC. Indeed, the high-affinity zinc-transport system, ZnuACB, contributed to the fitness of UPEC during experimental UTI [35, 36] .
5) Strategies for evading the host defenses
Another important factor that supports host colonization is the ability to evade the host immune response. Iron is a crucial nutrient that must be obtained by UPEC during an infection, and enterobactin represents one mechanism of iron procurement. On the other hand, the host protein lipocalin-2 issued by neutrophils specifically sticks to, and sequesters enterobactin, making it unable to provide UPEC with iron. Interestingly, UPEC can revise enterobactin by glycosylation; glycosylated enterobactin, known as salmochelin, are not identified and sequestered by lipocalin-2, enabling UPEC to escape the host defense mechanism mediated by lipocalin-2 [9, 37] . In addition, some UPEC strains encode the proteins, SisA and SisB, which suppress the host inflammatory response during the early stages of infection. A deletion of functional copies of these genes in UPEC causes significantly more inflammation in the host. Furthermore, a phase variation of type 1 fimbrial genes might assist UPEC in evading the immune system [38] .
Proteus mirabilis
1) Adherence
After the first attachment, P. mirabilis produces mannose- 2) Toxins P. mirabilis fabricates two toxins: hemolysin (HpmA) and
Proteus toxic agglutinin (Pta), which have been implicated in tissue damage and dissemination to the kidneys, initiating acute pyelonephritis [42] . Boht HpmA and Pta induce tissue damage during infection. On the other hand, Pta alone promotes the ability of P. mirabilis to colonize the urinary tract [43] .
HpmA is a Ca + -dependent pore-forming cytolysin that destabilizes the host cell by inserting itself into the cell membrane, causing Na + efflux [5] . On the other hand, the surface-associated cytotoxic protease, Pta, is functional only in alkaline pH, such as that generated by the activity of P. mirabilis urease. In the proposed mode of action, Pta penetrates the host cell membrane, causing osmotic stress, the leakage of cytosol, and the depolymerization of actin filaments. Therefore, the structural integrity of the cell is compromised, resulting in kidney and bladder damage.
Moreover, Pta induces bacterial cell-cell interactions via
autoaggregation [5, 41, 44] . On the other hand, a strain of P. mirabilis lacking flagella has been separated from a human patient, suggesting that flagella are not mandatory for its virulence [9, 45] .
3) Flagella-mediated motility
4) Metal acquisition
Historically, it was believed that P. mirabilis did not produce siderophores, unlike other members of the Enterobacteriaceae family. On the other hand, a microarray-based transcriptional study of P. mirabilis, cultured under Felimited conditions, revealed genes involved in Fe uptake, including siderophore systems, heme receptors, and receptors for exogenous siderophores. This study also led to the identification of proteobactin, a novel siderophore system, and a yersiniabactin-related siderophore system in P. mirabilis [46] , which were developed for Fe 3+ acquisition.
The yersiniabactin-related siderophore was originally recognized in a signature-tagged mutagenesis screen designed to detect the virulence factors in a murine UTI model and found to induce the successful colonization of the urinary bladder [34] . Moreover, P. mirabilis utilizes HmuR1 and HmuR2, which are outer membrane receptors that activate heme import. A loss of HmuR2 attenuated this process in both the kidney and bladder in a murine UTI model [47] . 
5) Strategies for evading host defenses
At least three mechanisms are used by P. mirabilis for immune evasion during a UTI. The first is the production of ZapA, a zinc metalloprotease capable of cleaving several host proteins, including serum and secretory IgA1, IgA2, and IgG, antimicrobial peptides (AMPs), and complement proteins [49] . ZapA activity was detected in the urine of infected patients, probably helping P. mirabilis colonize the urinary tract [9, 49] . In the second mechanism, P. mirabilis possibly utilizes MR/P fimbriae, which are capable of undergoing phase variation, to facilitate immune response avoidance.
In the third mechanism, flaA is the predominate version of flagellin expressed by P. mirabilis, whereas flaB is normally silent. On the other hand, upon recombination of these genes, P. mirabilis produces antigenically distinct flagella, enabling it to subvert the immune response [5, 9] . [50] , affording protection to P. mirabilis from the host immune system and antibiotics. Moreover, these structures block urine drainage from the ureters, potentially resulting in reflux and activating the progression to pyelonephritis, septicemia, and shock [41] . it permits access to underlying tissue that is normally unexposed despite the rapid differentiation of these underlying cells into superficial facet cells in response to exfoliation.
6) Urease production
MECHANISM OF THE HOST DEFENSES
Urine Flow and Cell Exfoliation
During a UPEC infection, this exfoliation results from an apoptosis-like mechanism that is promoted by FimH [9,51].
Innate Immune Response to UTI
AMPs are short, positively charged peptides that bind to and disrupt the bacterial membranes. For example, - as granulocyte-colony stimulating factor (G-CSF), are formed following a UPEC infection, but unlike G-CSF, they appear to limit the ability of UPEC to sustain a bladder infection [54, 55] . The functions of IL-17 and IL-10 in cell recruitment and immune regulation suggest that these cytokines potentially fine-tune the innate cellular defenses against UPEC in the bladder [56] . 
Adaptive Immune Response to UTI
In general, data regarding the adaptive immune response to UTI are sparse. Thumbikat et al. [59] reported that the protection originated from infection is antibody-mediated.
In addition, evidence implies that UPEC clearance is antibody-mediated. On the other hand, it is unclear if the immune response is skewed toward a TH1-mediated or TH2mediated response, and the role of TREG cells is unclear [9, 59] . Here, the following briefly summarizes the progress made towards the improvement of antivirulence therapeutics and the approaches for improving the current therapeutic options for UTIs with a special focus on vaccines. 
TREATMENT OF UTI
UPEC Vaccines
P. mirabilis Vaccines
In addition to the UPEC adhesins, those from P. mirabilis have been utilized as vaccine targets [65] . In a mouse model On the other hand, many of these inhibitors exhibit severe side effects related to toxicity [66] . Another group of urease inhibitors, phosphoramidites, exhibited potent activity against P. mirabilis urease in a mouse model. These elements, however, displayed low stability in the low pH of gastric juice, making them impractical [5, 66] . Finally, an immunoproteomic screen was performed to show the outer membrane proteins of P. mirabilis that could derive an immune response in infected mice [67] . These proteins are exciting new potential vaccine candidates because they are expressed in vivo and are exposed to the surface, where they can potentially interact with the host. Indeed, immunization with one of these proteins, Pta, protected mice from a subsequent transurethral challenge [41] . Therefore, there is interest in the generation of vaccines against both uropathogens. Although several studies focused on the development new strategies for the treatment and prevention of UTIs, more work is required. In addition, further studies will be needed to elucidate adaptive immune responses in the urinary tract. These findings will help better understand the disease process and provide new insights into novel therapeutic or prophylactic strategies in UTI.
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